A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection

Autor: Wong, R., Cunningham, D. *, Barbachano, Y., Saffery, C., Valle, J., Hickish, T., Mudan, S., Brown, G., Khan, A., Wotherspoon, A., Strimpakos, A.S., Thomas, J., Compton, S., Chua, Y.J., Chau, I.
Zdroj: In Annals of Oncology September 2011 22(9):2042-2048
Databáze: ScienceDirect